Gapping up
In reaction to strong earnings/guidance: LIFE +0.7%, CO +0.5%
M&A news: AMCN +45.7% (receives going private offer from group including Chairman and CEO for $6.00/share), ISSI +3.1% (Uphill raises ISSI bid to $22.00 per share, following yesterday's $21.25 Cypress raised offer), SYT +1.1% (cont M&A spec)
Select Airline related names showing strength: JBLU +1.3%, LUV +0.8%, UAL +0.7%
Other news: CAG +5.2% (Jana Partners discloses 7.2% active stake in 13D filing; prepared to make nominees to the Board), MNTA +4.4% (glatiramer acetate injection), a generic equivalent of daily COPAXONE), PRAN +3.7% (receives a $6.8 mln cash refund under the Australian Government's R&D Tax Incentive Scheme), SLI +2.9% (SLI Inc confirms it has received a non-binding proposal from Handy & Harman (HNH) to acquire all outstanding shares for a per share price of $43.00 to $45.00), BIOS +2.7% (announced June 25, 2015 record date for previously announced rights offering), NTIP +2.3% (authorized an increase to its previously announced share repurchase program), PSEC +0.9% (CEO disclosed purchase of 140K shares at $7.46 worth ~$1.04 mln)
Analyst comments: AERI +7.3% (upgraded to Buy from Hold at Canaccord Genuity), TGTX +3.6% (target raised to $28 at Brean Capital), CPXX +2.1% (initiated with a Buy at MLV & Co; $6 tgt), VG +1.9% (initiated with a Outperform at Oppenheimer), MU +1.3% (upgraded to Buy at Topeka Capital Markets), NFLX +1% (target raised to $800 from $610 at Oppenheimer)
In reaction to strong earnings/guidance: LIFE +0.7%, CO +0.5%
M&A news: AMCN +45.7% (receives going private offer from group including Chairman and CEO for $6.00/share), ISSI +3.1% (Uphill raises ISSI bid to $22.00 per share, following yesterday's $21.25 Cypress raised offer), SYT +1.1% (cont M&A spec)
Select Airline related names showing strength: JBLU +1.3%, LUV +0.8%, UAL +0.7%
Other news: CAG +5.2% (Jana Partners discloses 7.2% active stake in 13D filing; prepared to make nominees to the Board), MNTA +4.4% (glatiramer acetate injection), a generic equivalent of daily COPAXONE), PRAN +3.7% (receives a $6.8 mln cash refund under the Australian Government's R&D Tax Incentive Scheme), SLI +2.9% (SLI Inc confirms it has received a non-binding proposal from Handy & Harman (HNH) to acquire all outstanding shares for a per share price of $43.00 to $45.00), BIOS +2.7% (announced June 25, 2015 record date for previously announced rights offering), NTIP +2.3% (authorized an increase to its previously announced share repurchase program), PSEC +0.9% (CEO disclosed purchase of 140K shares at $7.46 worth ~$1.04 mln)
Analyst comments: AERI +7.3% (upgraded to Buy from Hold at Canaccord Genuity), TGTX +3.6% (target raised to $28 at Brean Capital), CPXX +2.1% (initiated with a Buy at MLV & Co; $6 tgt), VG +1.9% (initiated with a Outperform at Oppenheimer), MU +1.3% (upgraded to Buy at Topeka Capital Markets), NFLX +1% (target raised to $800 from $610 at Oppenheimer)